Male Infertility Epidemiology Forecast 2025-2034

Infertility is reported to affect 8% to 12% of couples, with a male factor acting as a primary or contributing factor in about 50% of the cases. The causes of male infertility are variable but are often linked to acquired, congenital, or idiopathic factors that affect spermatogenesis.

Male Infertility Epidemiology Forecast Report Coverage

The “Male Infertility Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of male infertility. It projects the future incidence and prevalence rates of male infertility across various populations. The study covers age and type as major determinants of the male infertility-affected population. The report highlights patterns in the prevalence of male infertility over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of male infertility in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Male Infertility: Disease Overview

Male infertility affects a man’s ability to contribute to conception. The condition is influenced by various medical, genetic, environmental, and lifestyle factors. Sperm-related issues such as low count, poor motility, or abnormal morphology can cause male infertility. Additionally, the rise in hormonal imbalances and medical conditions like varicocele or infection are increasing the number of male infertility cases. Environmental exposures to toxins, heavy metals, or radiation along with habits like smoking and excessive alcohol intake are suggested to affect sperm production.

Male Infertility: Treatment Overview

Depending on the underlying cause, male infertility may involve lifestyle changes, medications, surgeries, or assisted reproductive technologies (ART). In cases of autoimmune disorders, anti-inflammatory medications are used to prevent the body from attacking its own sperm. Hormonal treatments, such as gonadotropins or clomiphene citrate, are commonly prescribed to stimulate sperm production in patients with low testosterone or other hormone-related issues. When natural conception is not possible, assisted reproductive technologies offer advanced options for couples.

Epidemiology

The male infertility epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for male infertility by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for male infertility and their trends. The data is broken down into specific categories, such as the total diagnosed cases across different age groups and patient pools.

• Infertility is reported to affect 186 million individuals worldwide, with the male partner responsible for the infertility issue in nearly half of the cases.
• Various studies show that roughly 6% of men evaluated for male infertility are estimated to have more serious underlying medical conditions like cancer.
• Research has indicated that the fertility rates decline with advancing age. A 2020 study showed that conception is 30% less likely for males above 40 years compared to men aged less than 30 years.
• As per the British Fertility Society, up to 30% of fertility issues are due to men, 30% due to women, and 30% to 40% can be attributed to both or as a result of unknown causes.

Country-wise Male Infertility Epidemiology

The male infertility epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of male infertility varies significantly between countries due to differences in genetic factors, environmental exposures, lifestyle patterns, healthcare access, and cultural stigmas surrounding male infertility, among others. In the United States, nearly 15% of couples face issues while conceiving, and more than 50% of the time, it is due to a male infertility factor.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of male infertility based on several factors.
• Male Infertility Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population, and the unmet needs of male infertility are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of male infertility epidemiology in the 8 major markets?
• What will be the total number of patients with male infertility across the 8 major markets during the forecast period?
• What was the country-wise prevalence of male infertility in the 8 major markets in the historical period?
• Which country will have the highest number of male infertility patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of male infertility during the forecast period of 2025-2034?
• What are the currently available treatments for male infertility?
• What are the disease risks, signs, symptoms, and unmet needs of male infertility?

This product will be delivered within 3-5 business days.